awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33619161-CDEC6BC7-CD20-49AF-A067-CF610B986032
Q33619161-CDEC6BC7-CD20-49AF-A067-CF610B986032
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33619161-CDEC6BC7-CD20-49AF-A067-CF610B986032
Sodium-glucose Co-transporter 2 Inhibitors Reduce the Abdominal Visceral Fat Area and May Influence the Renal Function in Patients with Type 2 Diabetes.
P2860
Q33619161-CDEC6BC7-CD20-49AF-A067-CF610B986032
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33619161-CDEC6BC7-CD20-49AF-A067-CF610B986032
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f3c3d948048aa44cf1f9aee695356bdb42c1bb98
P2860
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus